Literature DB >> 1797552

Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens.

L G Sharpe1, N S Pilotte, W M Mitchell, E B De Souza.   

Abstract

The in vitro autoradiographic distribution of desipramine-insensitive specific [3H]mazindol binding sites (labelling the dopamine transporter) was determined in brain sections from rats receiving repeated i.v. infusions of saline or cocaine (1 mg/kg, every 12 min for 2 h/day), for 10 days. Brains were removed either within 15 min of or 10 days after the last treatment. A marked dorsal-to-ventral gradient in [3H]mazindol binding appeared in the striatum with the dorsal caudate putamen showing the greatest binding and the medial shell of the nucleus accumbens the least. Cocaine-associated changes in [3H]mazindol-labelled dopamine uptake sites occurred only in the nucleus accumbens (57 and 66% decrease in the lateral core and medial shell, respectively), of animals 10 days after the last treatment. Down-regulation of the dopamine transporter in the nucleus accumbens by withdrawal of chronic cocaine may be one of the mechanisms involved in cocaine's long-term abstinence effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797552     DOI: 10.1016/0014-2999(91)90804-y

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.

Authors:  M J Nirenberg; J Chan; A Pohorille; R A Vaughan; G R Uhl; M J Kuhar; V M Pickel
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 2.  The role of the dopamine transporter in cocaine abuse.

Authors:  Sari Izenwasser
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

3.  Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.

Authors:  S R Letchworth; M A Nader; H R Smith; D P Friedman; L J Porrino
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

4.  Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system.

Authors:  S R Tella; B Ladenheim; A M Andrews; S R Goldberg; J L Cadet
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

5.  Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment.

Authors:  S R Jones; T H Lee; R M Wightman; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

Review 6.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

7.  The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat.

Authors:  J M Wilson; S J Kish
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

8.  Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.

Authors:  L H Claye; H C Akunne; M D Davis; S DeMattos; K F Soliman
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

9.  Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.

Authors:  I Peraile; E Torres; A Mayado; M Izco; A Lopez-Jimenez; J A Lopez-Moreno; M I Colado; E O'Shea
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

10.  Dopamine transporter levels in cocaine dependent subjects.

Authors:  Paul Crits-Christoph; Andrew Newberg; Nancy Wintering; Karl Ploessl; Mary Beth Connolly Gibbons; Sarah Ring-Kurtz; Robert Gallop; Julie Present
Journal:  Drug Alcohol Depend       Date:  2008-06-20       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.